Indolent T-Cell Non-Hodgkin Lymphoma — Trials

Indolent T-Cell Non-Hodgkin Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

134 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 33
Recruiting: 16
Ph III recruiting: 0
Growth YoY: —
Industry share: 15%
Top sponsor: City of Hope Medical Center
Termination share: 46.8%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (31)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07235813	IL-35: A Key Immunosuppressive Driver in Mycosis Fungoides Modulated by Phototherapy	completed	N/A	16	Kasr El Aini HospitalOTHER	1	Nov 19, 2025	clinicaltrials
NCT05303480	Deep Phenotyping of Cutaneous T Cell Lymphoma, Type Mycosis Fungoides	completed	N/A	32	Centre for Human Drug Research, NetherlandsOTHER	1	Jan 25, 2023	clinicaltrials